Author picture

Sen. Eric Schmitt (R-MO)

Tenure: 118th–119th Congresses
Years of Service: 2023–Present

Notable Actions
119th Congress

✅ Lead sponsor of the Worldwide Animal Testing Compliance and Harmonization (WATCH) Act, S. 1104, bipartisan legislation to require quarterly inspections of foreign laboratories receiving NIH funding for animal research to ensure compliance with animal welfare standards and suspend or revoke federal funding for facilities that fail to correct violations.

✅ Cosponsor of the Fighting Inhumane Gambling and High-Risk Trafficking (FIGHT) Act, S. 1454, to strengthen federal enforcement against animal fighting and related criminal activity.

✅ Lead cosponsor of FDA Modernization Act 3.0, S. 355, to direct FDA to publish a final rule to implement a law enacted in December 2022 that eliminated a Depression-era requirement for animal testing in the Federal Food, Drug and Cosmetic Act (21 USC § 355) and allows for innovative 21st-century human-relevant test methods where appropriate.

❌ Voted “Yea” on S.J. Res. 23 (Senate Roll Call Vote 122), a Congressional Review Act resolution to overturn federal regulations strengthening implementation of the Endangered Species Act, including protections governing the listing of imperiled species and designation of critical habitat. A “Yea” vote is the anti-animal position because it supported eliminating stronger protections for threatened and endangered wildlife and their habitat.

❌ Voted “Nay” on the motion to proceed to S.J. Res. 69 (Senate Roll Call Vote 597), a joint resolution under the Congressional Review Act to bring the measure before the Senate for consideration to overturn the U.S. Fish and Wildlife Service’s Barred Owl Management Strategy, which authorized the large-scale killing of barred owls in Washington, Oregon, and California. A “Nay” vote is the anti-animal position because it opposed moving forward with a vote to repeal the barred owl kill plan.

118th Congress

✅ Lead cosponsor of FDA Modernization Act 3.0, S. 5046, to direct FDA to publish a final rule to implement a law enacted in December 2022 that eliminated a Depression-era requirement for animal testing in the Federal Food, Drug and Cosmetic Act (21 USC § 355) and allows for innovative 21st-century human-relevant test methods where appropriate.